NEUROCRINE BIOSCIENCES INC (NBIX) › Capital ExpendituresNEUROCRINE BIOSCIENCES INC (NBIX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $35.0K2010: $315.0K2011: $750.0K2012: $971.0K2013: $545.0K2014: $1.61M2015: $1.93M2016: $4.11M2017: $6.94M2018: $24.80M2019: $14.70M2020: $10.90M2021: $23.40M2022: $16.50M2023: $28.30M2024: $38.20M2025: $34.00M$34.00M2009Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$34.00M-11.0%2024$38.20M+35.0%2023$28.30M+71.5%2022$16.50M-29.5%2021$23.40M+114.7%2020$10.90M-25.9%2019$14.70M-40.7%2018$24.80M+257.3%2017$6.94M+68.9%2016$4.11M+112.4%2015$1.93M+20.0%2014$1.61M+195.8%2013$545.0K-43.9%2012$971.0K+29.5%2011$750.0K+138.1%2010$315.0K+800.0%2009$35.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share